New Delhi: Medical device manufacturers have been left disappointed by the Budget 2018-19, saying their concerns have not been addressed.
Although they welcomed Finance Minister Arun Jaitley’s mega healthcare proposal saying it was a step in the right direction, domestic medical devices makers said promised reforms and anticipated conducive measures to boost local manufacturing have not happened.
On the other hand, associations such as Medical Technology Association of India (MTaI) and AdvaMed said the government should not dis-incentivize technical innovation by medical device manufacturers.
Though the Budgets focus on providing universal healthcare services is a step in the right direction for building a healthy nation, the domestic industry is left in the lurch by not giving it necessary protection against imports, he added.
“Nominal tweaking in customs duty applicable to medical devices is urgently needed to address Rs 27,300 crore import bill and 70-90 percent import dependency,” Nath said.
One of the important steps the government needs to take is to increase the basic import duty on medical devices in the range of 10-15 percent to make manufacturing more viable than importing, and give nominal protection to investors, he added.
Taking a contrarian line, Medical Technology Association of India (MTaI) Chairman & DG Pavan Choudary said: “While access to basic healthcare is an important determinant of Universal Healthcare, another critical factor is quality of healthcare”.
The latter requires access to advance healthcare technology for best health management of patients. The government should have looked at incentivizing import of advanced medical devices into the country by bringing down the customs duty, he added.
Under the current ecosystem more than 70 percent of medical devices have to be imported from abroad, Choudary said.
He further said a balanced approach to reduce the cost to the patient is trade margin rationalization for distributors, gradation in pricing thereby allowing a higher price bracket for superior medical devices and lower customs duty.
There is also a need to undo the un-nuanced price control imposed by NPPA as it is leading to unintended consequences on healthcare ecosystem without any significant reduction in the cost of patients, he added.
Advanced Medical Technology Association (AdvaMed) also said: “We are truly encouraged with the Union Budgets to focus on healthcare and the governments continued commitment towards achieving the long-term goal of universal health coverage”.
While the Budget this year has exhibited many positives, the industry continues to urge the government of India to promote an enabling environment for the medical devices sector that is conducive to innovation, patient access, and patient choice, it added.
AdvaMed said there is a need for more scientific approaches that facilitate differential pricing for innovative medical technologies.